| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| R&D Expense | $9.4M | -28.0% |
| SG&A Expense | $8.5M | -4.9% |
| Operating Income | -$17.9M | +18.6% |
| Pre-tax Income | -$15.6M | +27.6% |
| Income Tax | -$87K | +37.3% |
| Net Income | -$15.5M | +27.5% |
| EPS (Basic) | -$0.01 | +50.0% |
| EPS (Diluted) | -$0.01 | +50.0% |
| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $12.6M | +4.2% |
| Accounts Receivable | $127K | -70.2% |
| Current Assets | $13.2M | -1.0% |
| Total Assets | $27.6M | -3.2% |
| Current Liabilities | $3.8M | +39.8% |
| Total Liabilities | $10.2M | +55.0% |
| Stockholders' Equity | $17.5M | -20.5% |
| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$14.7M | -0.3% |
| Financing Cash Flow | $15.1M | +291.6% |